Jack Dean

Jack Dean

Directeur/Membre du Conseil chez ACURX PHARMACEUTICALS, INC.

Fortune : 2 726 $ au 31/05/2026

84 ans
Health Technology
Commercial Services
Consumer Services

Profil

Jack Hugh Dean was the founder of Dipexium Pharmaceuticals, Inc. since 2010, holding the title of Director from 2010 to 2014.
Current jobs include Director at ReSearch Pharmaceutical Services LLC since 2008, Independent Director at Acurx Pharmaceuticals, Inc. since 2021, President at Drug Development Advisors LLC since 2006, Trustee at ILSI Health & Environmental Sciences Institute since 1994, and Professor at the University of Arizona College of Pharmacy since 2006.
Former jobs include Global Director-Preclinical Development at Sanofi from 1988 to 2006, Director at PLx Pharma, Inc. from 2010 to 2017, Director at Sanofi-Synthelabo, Inc., Director at Sterling Winthrop Pharmaceuticals Research Center from 1990 to 1992, Director-Department of Immunology at Litton Bionetics, Inc. from 1975 to 1979, Professor at UNC Chapel Hill Foundation Investment Fund, Inc. from 1981 to 1988, Vice President-Drug Safety at Sterling Winthrop, Inc. from 1989 to 1992, Head-National Toxicology Program at National Institutes of Health from 1982 to 1988, President-US Science & Medical Affairs at Sanofi-Aventis U.S.
LLC from 1988 to 2006, Head-Immunotoxicology Section at The National Institute of Environmental Health Sciences from 1982 to 1988, and Head-Cellular & Molecular Toxicology Department at The Hamner Institutes for Health Sciences from 1982 to 1988.
Education includes undergraduate and graduate degrees from The California State University and a doctorate from the University of Arizona College of Medicine conferred in 1972.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/04/2026 1 377 ( 0,09% ) 2 726 $ 31/05/2026

Postes actifs de Jack Dean

SociétésPosteDébut
ACURX PHARMACEUTICALS, INC. Directeur/Membre du Conseil 24/06/2021
Directeur/Membre du Conseil 12/05/2008
Corporate Officer/Principal 01/01/2006
Directeur/Membre du Conseil 01/01/1994
Drug Development Advisors LLC
President 01/01/2006

Anciens postes connus de Jack Dean

SociétésPosteFin
PLX PHARMA WINDDOWN CORP. Directeur/Membre du Conseil 01/04/2017
Directeur Technique/Scientifique/R&D 01/01/2006
SANOFI Corporate Officer/Principal 01/01/2006
Sterling Winthrop Pharmaceuticals Research Center
Directeur/Membre du Conseil 01/01/1992
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jack Dean

Formation de Jack Dean

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Health Technology

Consumer Durables

Commercial Services

Consumer Services

Government

Health Technology

Commercial Services

Sanofi-Synthelabo, Inc.

Health Technology

Sterling Winthrop Pharmaceuticals Research Center

Commercial Services

Drug Development Advisors LLC

Litton Bionetics, Inc.

Consumer Services

Consumer Services

UNC Chapel Hill Foundation Investment Fund, Inc.

Health Technology

Health Technology